Combined Estrogen Suppression and Receptor (ER) Blockade by Buserelin (LHRH-A) and Tamoxifen (TAM) in Premenopausal Metastatic Breast Cancer: Preliminary Results of a 3-Arm Randomized Study (EORTC 10881)

Authors: Klijn J.G.M.; Seynaeve C.; Beex L.; Mauriac L.; van Zijl J.; Veyret C.; Wildiers J.; Jassem J.; Burghouts J.; Becquart M.; Namer M.; Piccart M.; Garcia-Conde J.; Mignolet F.; Hoctin-Boes G.

Source: European Journal of Cancer, Volume 32, Supplement 2, 10 September 1996 , pp. 49-49(1)

Publisher: Elsevier

Language: English

Document Type: Abstract

DOI: http://dx.doi.org/10.1016/0959-8049(96)84236-5

Publication date: 1996-09-10

• In this: publication
• By this: publisher
• In this Subject: Oncology
• By this author: Klijn J.G.M. ;  Seynaeve C. ;  Beex L. ;  Mauriac L. ;  van Zijl J. ;  Veyret C. ;  Wildiers J. ;  Jassem J. ;  Burghouts J. ;  Becquart M. ;  Namer M. ;  Piccart M. ;  Garcia-Conde J. ;  Mignolet F. ;  Hoctin-Boes G.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers